Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.

Also called NCT03354897

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 228 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03354897
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03354897. Allocation not applicable; no masking; primary purpose treatment. Start 2017-04-05 (actual); primary completion 2021-10-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
Acronym
UMOD
Condition
Cardiovascular Diseases
Condition
Hypertension
Intervention (Drug)
Torasemide 5Mg Tablet
Lead sponsor
NHS Greater Glasgow and Clyde (class: other)
Collaborator
University of Glasgow (class: other)
Collaborator
British Heart Foundation (class: other)

Record details

Record id
cardio:ct-nct03354897
Content hash
f42c1cb1fbab4825189394cdf85773d0c872f09cbfc0f3c2999de72f511ca04a